Skip to main content
SpringerLink
Log in

Palliative Management for Advanced Colorectal Cancer

  • Chapter
  • First Online:
Surgical Treatment of Colorectal Cancer

  • 1280 Accesses

Abstract

Over the last two decades, the concept of “palliative” has changed due to the pivotal role of multidisciplinary approach and chemotherapy. Incurable CRC patients may be asymptomatic or present various symptoms from dyspepsia to life-threatening conditions such as malignant obstruction, perforation, and lower gastrointestinal bleeding which needs emergency surgical intervention. The overall survival is still the main endpoint of palliative management in CRC patients. But the quality of residual life affected by surgery, chemotherapy, and any other palliative treatment should not be underestimated but should be an immensely important issue. Multidisciplinary approach is needed for appropriate management to control the symptoms and to improve the quality of life of patients with disease progression and incurable CRC.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Cirocchi R, Trastulli S, Abraha I, Vettoretto N, Boselli C, Montedori A, et al. Non-resection versus resection for an asymptomatic primary tumour in patients with unresectable stage IV colorectal cancer. Cochrane Database Syst Rev. 2012;(8):Cd008997. https://doi.org/10.1002/14651858.CD008997.pub2.

  2. Golan T, Urban D, Berger R, Lawrence YR. Changing prognosis of metastatic colorectal adenocarcinoma: differential improvement by age and tumor location. Cancer. 2013;119(16):3084–91. https://doi.org/10.1002/cncr.28143.

    Article  PubMed  Google Scholar 

  3. Petrelli N, Herrera L, Rustum Y, Burke P, Creaven P, Stulc J, et al. A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma. J Clin Oncol Off J Am Soc Clin Oncol. 1987;5(10):1559–65. https://doi.org/10.1200/jco.1987.5.10.1559.

    Article  CAS  Google Scholar 

  4. Saltz LB, Douillard JY, Pirotta N, Alakl M, Gruia G, Awad L, et al. Irinotecan plus fluorouracil/leucovorin for metastatic colorectal cancer: a new survival standard. Oncologist. 2001;6(1):81–91.

    Article  CAS  PubMed  Google Scholar 

  5. Zisis C, Tsakiridis K, Kougioumtzi I, Zarogoulidis P, Darwiche K, Machairiotis N, et al. The management of the advanced colorectal cancer: management of the pulmonary metastases. J Thorac Dis. 2013;5(Suppl 4):S383–8. https://doi.org/10.3978/j.issn.2072-1439.2013.06.23.

    Article  PubMed  PubMed Central  Google Scholar 

  6. van de Velde CJ, Boelens PG, Borras JM, Coebergh JW, Cervantes A, Blomqvist L, et al. EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectum. Eur J Cancer. 2014;50(1):1.e1–1.e34. https://doi.org/10.1016/j.ejca.2013.06.048.

    Article  Google Scholar 

  7. Van Cutsem E, Cervantes A, Adam R, Sobrero A, Van Krieken JH, Aderka D, et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol Off J Eur Soc Med Oncol. 2016;27(8):1386–422. https://doi.org/10.1093/annonc/mdw235.

    Article  Google Scholar 

  8. Chang GJ, Kaiser AM, Mills S, Rafferty JF, Buie WD. Practice parameters for the management of colon cancer. Dis Colon Rectum. 2012;55(8):831–43. https://doi.org/10.1097/DCR.0b013e3182567e13.

    Article  PubMed  Google Scholar 

  9. Saltz LB, Cox JV, Blanke C, Rosen LS, Fehrenbacher L, Moore MJ, et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. N Engl J Med. 2000;343(13):905–14. https://doi.org/10.1056/nejm200009283431302.

    Article  CAS  PubMed  Google Scholar 

  10. Venook AP, Niedzwiecki D, Lenz H-J, Innocenti F, Mahoney MR, O'Neil BH, et al. CALGB/SWOG 80405: phase III trial of irinotecan/5-FU/leucovorin (FOLFIRI) or oxaliplatin/5-FU/leucovorin (mFOLFOX6) with bevacizumab (BV) or cetuximab (CET) for patients (pts) with KRAS wild-type (wt) untreated metastatic adenocarcinoma of the colon or rectum (MCRC). Proc Am Soc Clin Oncol. 2014;32(5s):LBA3.

    Article  Google Scholar 

  11. Benson AB 3rd, Bekaii-Saab T, Chan E, Chen YJ, Choti MA, Cooper HS, et al. Metastatic colon cancer, version 3.2013: featured updates to the NCCN guidelines. J Natl Compr Cancer Netw. 2013;11(2):141–52.

    Article  CAS  Google Scholar 

  12. Folkert IW, Roses RE. Value in palliative cancer surgery: a critical assessment. J Surg Oncol. 2016;114(3):311–5. https://doi.org/10.1002/jso.24303.

    Article  PubMed  Google Scholar 

  13. Miner TJ, Cohen J, Charpentier K, McPhillips J, Marvell L, Cioffi WG. The palliative triangle: improved patient selection and outcomes associated with palliative operations. Arch Surg. 2011;146(5):517–22. https://doi.org/10.1001/archsurg.2011.92.

    Article  PubMed  Google Scholar 

  14. Law WL, Choi HK, Chu KW, Ho JW, Wong L. Bowel preparation for colonoscopy: a randomized controlled trial comparing polyethylene glycol solution, one dose and two doses of oral sodium phosphate solution. Asian J Surg. 2004;27(2):120–4. https://doi.org/10.1016/s1015-9584(09)60324-9.

    Article  PubMed  Google Scholar 

  15. Marquis P, Marrel A, Jambon B. Quality of life in patients with stomas: the Montreux study. Ostomy Wound Manage. 2003;49(2):48–55.

    PubMed  Google Scholar 

  16. Fuhrman GM, Ota DM. Laparoscopic intestinal stomas. Dis Colon Rectum. 1994;37(5):444–9.

    Article  CAS  PubMed  Google Scholar 

  17. Fleshman JW, Nelson H, Peters WR, Kim HC, Larach S, Boorse RR, et al. Early results of laparoscopic surgery for colorectal cancer. Retrospective analysis of 372 patients treated by clinical outcomes of surgical therapy (COST) study group. Dis Colon Rectum. 1996;39(10 Suppl):S53–8.

    Article  CAS  PubMed  Google Scholar 

  18. Rosen SA, Buell JF, Yoshida A, Kazsuba S, Hurst R, Michelassi F, et al. Initial presentation with stage IV colorectal cancer: how aggressive should we be? Arch Surg. 2000;135(5):530–4.

    Article  CAS  PubMed  Google Scholar 

  19. Law WL, Chan WF, Lee YM, Chu KW. Non-curative surgery for colorectal cancer: critical appraisal of outcomes. Int J Color Dis. 2004;19(3):197–202. https://doi.org/10.1007/s00384-003-0551-7.

    Article  Google Scholar 

  20. Zhao XD, Cai BB, Cao RS, Shi RH. Palliative treatment for incurable malignant colorectal obstructions: a meta-analysis. World J Gastroenterol. 2013;19(33):5565–74. https://doi.org/10.3748/wjg.v19.i33.5565.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Sagar J. Role of colonic stents in the management of colorectal cancers. World J Gastrointest Endosc. 2016;8(4):198–204. https://doi.org/10.4253/wjge.v8.i4.198.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Dohmoto M, Hunerbein M, Schlag PM. Application of rectal stents for palliation of obstructing rectosigmoid cancer. Surg Endosc. 1997;11(7):758–61.

    Article  CAS  PubMed  Google Scholar 

  23. Liang TW, Sun Y, Wei YC, Yang DX. Palliative treatment of malignant colorectal obstruction caused by advanced malignancy: a self-expanding metallic stent or surgery? A system review and meta-analysis. Surg Today. 2014;44(1):22–33. https://doi.org/10.1007/s00595-013-0665-7.

    Article  CAS  PubMed  Google Scholar 

  24. Small AJ, Coelho-Prabhu N, Baron TH. Endoscopic placement of self-expandable metal stents for malignant colonic obstruction: long-term outcomes and complication factors. Gastrointest Endosc. 2010;71(3):560–72. https://doi.org/10.1016/j.gie.2009.10.012.

    Article  PubMed  Google Scholar 

  25. van Halsema EE, van Hooft JE, Small AJ, Baron TH, Garcia-Cano J, Cheon JH, et al. Perforation in colorectal stenting: a meta-analysis and a search for risk factors. Gastrointest Endosc. 2014;79(6):970-82.e7. https://doi.org/10.1016/j.gie.2013.11.038.

    Article  Google Scholar 

  26. Cennamo V, Fuccio L, Mutri V, Minardi ME, Eusebi LH, Ceroni L, et al. Does stent placement for advanced colon cancer increase the risk of perforation during bevacizumab-based therapy? Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2009;7(11):1174–6. https://doi.org/10.1016/j.cgh.2009.07.015.

    Article  Google Scholar 

  27. Lo SK. Metallic stenting for colorectal obstruction. Gastrointest Endosc Clin N Am. 1999;9(3):459–77.

    CAS  PubMed  Google Scholar 

  28. Gash K, Chambers W, Ghosh A, Dixon AR. The role of laparoscopic surgery for the management of acute large bowel obstruction. Colorectal Dis Off J Assoc Coloproctol G B Irel. 2011;13(3):263–6. https://doi.org/10.1111/j.1463-1318.2009.02123.x.

    Article  CAS  Google Scholar 

  29. Smithers BM, Theile DE, Cohen JR, Evans EB, Davis NC. Emergency right hemicolectomy in colon carcinoma: a prospective study. Aust N Z J Surg. 1986;56(10):749–52.

    Article  CAS  PubMed  Google Scholar 

  30. Kimmey MB. Endoscopic methods (other than stents) for palliation of rectal carcinoma. J Gastrointest Surg. 2004;8(3):270–3. https://doi.org/10.1016/j.gassur.2003.11.017.

    Article  PubMed  Google Scholar 

  31. Saltz LB. Palliative management of rectal cancer: the roles of chemotherapy and radiation therapy. J Gastrointest Surg. 2004;8(3):274–6. https://doi.org/10.1016/j.gassur.2003.11.016.

    Article  PubMed  Google Scholar 

  32. Stelzner S, Hellmich G, Koch R, Ludwig K. Factors predicting survival in stage IV colorectal carcinoma patients after palliative treatment: a multivariate analysis. J Surg Oncol. 2005;89(4):211–7. https://doi.org/10.1002/jso.20196.

    Article  PubMed  Google Scholar 

  33. Costi R, Leonardi F, Zanoni D, Violi V, Roncoroni L. Palliative care and end-stage colorectal cancer management: the surgeon meets the oncologist. World J Gastroenterol. 2014;20(24):7602–21. https://doi.org/10.3748/wjg.v20.i24.7602.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Lutz ST, Jones J, Chow E. Role of radiation therapy in palliative care of the patient with cancer. J Clin Oncol Off J Am Soc Clin Oncol. 2014;32(26):2913–9. https://doi.org/10.1200/jco.2014.55.1143.

    Article  Google Scholar 

  35. Janjan NA, Breslin T, Lenzi R, Rich TA, Skibber J. Avoidance of colostomy placement in advanced colorectal cancer with twice weekly hypofractionated radiation plus continuous infusion 5-fluorouracil. J Pain Symptom Manag. 2000;20(4):266–72.

    Article  CAS  Google Scholar 

  36. Allum WH, Mack P, Priestman TJ, Fielding JW. Radiotherapy for pain relief in locally recurrent colorectal cancer. Ann R Coll Surg Engl. 1987;69(5):220–1.

    CAS  PubMed  PubMed Central  Google Scholar 

  37. Santini D, Tampellini M, Vincenzi B, Ibrahim T, Ortega C, Virzi V, et al. Natural history of bone metastasis in colorectal cancer: final results of a large Italian bone metastases study. Ann Oncol Off J Eur Soc Med Oncol. 2012;23(8):2072–7. https://doi.org/10.1093/annonc/mdr572.

    Article  CAS  Google Scholar 

  38. Lutz S, Berk L, Chang E, Chow E, Hahn C, Hoskin P, et al. Palliative radiotherapy for bone metastases: an ASTRO evidence-based guideline. Int J Radiat Oncol Biol Phys. 2011;79(4):965–76. https://doi.org/10.1016/j.ijrobp.2010.11.026.

    Article  PubMed  Google Scholar 

  39. Cunningham D, Lang I, Marcuello E, Lorusso V, Ocvirk J, Shin DB, et al. Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial. Lancet Oncol. 2013;14(11):1077–85. https://doi.org/10.1016/s1470-2045(13)70154-2.

    Article  CAS  PubMed  Google Scholar 

  40. Loupakis F, Cremolini C, Masi G, Lonardi S, Zagonel V, Salvatore L, et al. Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer. N Engl J Med. 2014;371(17):1609–18. https://doi.org/10.1056/NEJMoa1403108.

    Article  PubMed  Google Scholar 

  41. Gruenberger T, Bridgewater J, Chau I, Garcia Alfonso P, Rivoire M, Mudan S, et al. Bevacizumab plus mFOLFOX-6 or FOLFOXIRI in patients with initially unresectable liver metastases from colorectal cancer: the OLIVIA multinational randomised phase II trial. Ann Oncol Off J Eur Soc Med Oncol. 2015;26(4):702–8. https://doi.org/10.1093/annonc/mdu580.

    Article  CAS  Google Scholar 

  42. Cremolini C, Loupakis F, Antoniotti C, Lupi C, Sensi E, Lonardi S, et al. FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study. Lancet Oncol. 2015;16(13):1306–15. https://doi.org/10.1016/s1470-2045(15)00122-9.

    Article  CAS  PubMed  Google Scholar 

  43. Adam R, de Gramont A, Figueras J, Kokudo N, Kunstlinger F, Loyer E, et al. Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus. Cancer Treat Rev. 2015;41(9):729–41. https://doi.org/10.1016/j.ctrv.2015.06.006.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Yonsei University College of Medicine, Seoul, South Korea

    Seung Yoon Yang, Jong Min Lee & Nam Kyu Kim

Authors
  1. Seung Yoon Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jong Min Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nam Kyu Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Seung Yoon Yang or Nam Kyu Kim .

Editor information

Editors and Affiliations

  1. Department of Surgery, Yonsei University College of Medicine, Seoul, Korea (Republic of)

    Nam Kyu Kim

  2. Department of Surgery, Tokyo Medical and Dental University, Tokyo, Japan

    Kenichi Sugihara

  3. Department of Surgery, National Taiwan University Hospital and College of Medicine, Taipei City, Taiwan

    Jin-Tung Liang

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Yang, S.Y., Lee, J.M., Kim, N.K. (2018). Palliative Management for Advanced Colorectal Cancer. In: Kim, N., Sugihara, K., Liang, JT. (eds) Surgical Treatment of Colorectal Cancer. Springer, Singapore. https://doi.org/10.1007/978-981-10-5143-2_37

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-5143-2_37

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-5142-5

  • Online ISBN: 978-981-10-5143-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation